Skip to content

Moderna’s Covid Shot for Children and Teens Wins Panel’s Support

Moderna Inc.’s Covid-19 vaccine for children and teens gained the support of a panel of US regulatory advisers, putting the shot on track for likely clearance.

The Food and Drug Administration’s 22-member vaccines advisory committee voted unanimously to back authorization of the immunization, intended for children and adolescents 6 to 17 years old. The vote was split into considerations of doses for children 6 to 11 years old and 12 to 17 years old.